The holiday season is a time when we count our blessings and shower gifts on those we love. It's also the time when we vow to do better in the coming year.
Before the mass resignations at The New Republic, one of the new executives hired by its 31-year-old sugar-daddy owner reportedly asked for a "listicle" on “10 reasons why healthcare isn't a free market.” He didn't get it, but what a great idea.
Slower growth in healthcare spending is supposed to boost the general economy in ways similar to the current drop in oil prices, which retailers hope will save them from a disastrous holiday shopping season. So why are people cheering the latter but not the former?
That's the updated estimate of the cost to develop a new drug from the Tufts Center for the Study of Drug Development. Anyone with even a rudimentary understanding of corporate accounting knows the claim is bogus.
No one likes the idea of physicians practicing cookbook medicine. Yet providers and insurers increasingly are asking physicians to use preordained treatment plans called clinical pathways.
Talk about sending mixed messages. Robert McDonald, the new head of the Veterans Affairs Department, wants to hire 28,000 new doctors, nurses and other clinical staff to reduce delays in offering care to the nation's growing VA-eligible population.
After an election where opposing the Patient Protection and Affordable Care Act once again served as a path to political power, it's important to remind politicians about how the law's two distinct sections interact.
“(The arrival home of) Kaci Hickox ... was a perfect teachable moment.
Some states across the country are imposing stringent and unnecessary quarantine requirements on healthcare workers exposed to Ebola patients.
Remember the excitement surrounding Castlight Health's initial public offering? Last March, the San Francisco startup's stock price soared when investors bought into the idea that online price transparency would transform the healthcare marketplace.
The U.S. healthcare system badly fumbled its first unexpected encounter with the deadly Ebola virus. One misdiagnosed patient is dead, two nurses who treated him are sick, and hundreds of people may have been exposed to the virus. Panic is spreading.
The initial release of data on payments made by medical product manufacturers to individual physicians and teaching hospitals proves once again that anyone dealing with large amounts of data—including the government—rarely gets it right the first time around.